Dr Rochelle Deanne Cochrane, MD | |
2517 Ne Kresky Avenue, Chehalis, WA 98532-2409 | |
(360) 748-8632 | |
(360) 748-3869 |
Full Name | Dr Rochelle Deanne Cochrane |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 20 Years |
Location | 2517 Ne Kresky Avenue, Chehalis, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063606374 | NPI | - | NPPES |
K171923 | Other | AK | MEDICARE AK |
2167179 | Medicaid | WA | |
G9017174 | Other | WA | MEDICARE WA |
G9017171 | Other | WA | MEDICARE WA |
G9017173 | Other | WA | MEDICARE WA |
G9017172 | Other | WA | MEDICARE WA |
1708987 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | A104458 (California) | Secondary |
207W00000X | Ophthalmology | 159123 (Alaska) | Secondary |
207W00000X | Ophthalmology | MD61054774 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
News Archive
Low levels of high-density lipoproteins (HDL) - the "good" cholesterol - in middle age may increase the risk of memory loss and lead to dementia later in life, researchers reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
Anirban Chatterjee, chief of health and nutrition for UNICEF in Ghana, said the country "is doing a lot" to fight child mortality - referring to a recently launched vaccination campaign and an initiative to educate mothers about nutrition - but "I don't think it's enough" to reach the fourth U.N. Millennium Development Goal (MDG) to reduce the under-five mortality rate by two thirds by 2015, Inter Press Service reports.
Cannabis withdrawal symptoms are clinically significant in schizophrenia patients as they are often associated with behavioral change, say researchers.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Researchers at Johns Hopkins have found that nighttime flying and worsening weather conditions are two key characteristics of fatal plane crashes in general aviation where alcohol consumption by the pilot was also a factor.
› Verified 7 days ago
Entity Name | Pacific Cataract And Laser Institute Inc Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306013925 PECOS PAC ID: 7517864119 Enrollment ID: O20040213000312 |
News Archive
Low levels of high-density lipoproteins (HDL) - the "good" cholesterol - in middle age may increase the risk of memory loss and lead to dementia later in life, researchers reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
Anirban Chatterjee, chief of health and nutrition for UNICEF in Ghana, said the country "is doing a lot" to fight child mortality - referring to a recently launched vaccination campaign and an initiative to educate mothers about nutrition - but "I don't think it's enough" to reach the fourth U.N. Millennium Development Goal (MDG) to reduce the under-five mortality rate by two thirds by 2015, Inter Press Service reports.
Cannabis withdrawal symptoms are clinically significant in schizophrenia patients as they are often associated with behavioral change, say researchers.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Researchers at Johns Hopkins have found that nighttime flying and worsening weather conditions are two key characteristics of fatal plane crashes in general aviation where alcohol consumption by the pilot was also a factor.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rochelle Deanne Cochrane, MD Po Box 1506, Chehalis, WA 98532 Ph: (800) 888-9960 | Dr Rochelle Deanne Cochrane, MD 2517 Ne Kresky Avenue, Chehalis, WA 98532-2409 Ph: (360) 748-8632 |
News Archive
Low levels of high-density lipoproteins (HDL) - the "good" cholesterol - in middle age may increase the risk of memory loss and lead to dementia later in life, researchers reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
Anirban Chatterjee, chief of health and nutrition for UNICEF in Ghana, said the country "is doing a lot" to fight child mortality - referring to a recently launched vaccination campaign and an initiative to educate mothers about nutrition - but "I don't think it's enough" to reach the fourth U.N. Millennium Development Goal (MDG) to reduce the under-five mortality rate by two thirds by 2015, Inter Press Service reports.
Cannabis withdrawal symptoms are clinically significant in schizophrenia patients as they are often associated with behavioral change, say researchers.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Researchers at Johns Hopkins have found that nighttime flying and worsening weather conditions are two key characteristics of fatal plane crashes in general aviation where alcohol consumption by the pilot was also a factor.
› Verified 7 days ago
Dr. Gordon E Johns, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-807-7687 | |
Dr. Robert Orland Ford, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Dr. Paul Y Chung, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Ronald K Sugiyama, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 | |
Dr. Robert Marshall Ford, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Dr. Jason Leng, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |